Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 - 04/05/21
, Alexandre Naime Barbosa, MD, PhD b, Bruno Scarpellini, MD, PhD c, Décio Diament, MD, PhD a, Eduardo Alexandrino Medeiros, MD, PhD d, Estevão Urbano Silva, MD e, Karen Mirna Loro Morejón, MD, PhD f, Priscila Rosalba Domingos Oliveira, MD, PhD g, Raquel Silveira Bello Stucchi, MD, PhD h, Roseane Porto Medeiros, MD, MSc i, j, Sérgio Cimerman, MD, PhD a, Tânia Regina Constant Vergara, MD, PhD k, Clóvis Arns Cunha, MD, MSc l| Funding: None. |
|
| Conflicts of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 134 - N° 5
P. e341-e342 - mai 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
